InsidersTradesSigma
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Discover the full record of transactions filed by Hemrajani Rekha. Director active across 3 companies, notably BioAge Labs, Inc.. Aggregated, 5 reports have been logged. Split: 2 buys · 1 sell. Total volume traded: €111k. History available since 11 June 2024. The latest transaction was disclosed on 25 June 2025 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations
Hemrajani Rekha is a director of Maxcyte, INC., BioAge Labs, Inc. and ALX Oncology Holdings INC. Across the 5 known filings, the recent filings observed between 2024-06-13 and 2025-08-27 show EUR 92318 of buys and EUR 19153 of sells, with the modal transaction nature listed as Attribution.